| 英文别名 |
N-(4-(4-(4-Fluorophenyl)piperazin-1-yl)butan-2-yl)nicotinamide;Niaprazine [INN:DCF];1709 CERM;BRN 0844157;N-(3-(4-(4-Fluorophenyl)-1-piperazinyl)-1-methylpropyl)-3-pyridinecarboxamide;N-(3-(4-(p-Fluorophenyl)-1-piperazinyl)-1-methylpropyl)nicotinamide;Niaprazina;Niaprazina [INN-Spanish];N-[4-[4-(4-fluorophenyl)piperazin-1-yl]butan-2-yl]pyridine-3-carboxamide;Niaprazine;3-Pyridinecarboxamide, N-(3-(4-(4-fluorophenyl)-1-piperazinyl)-1-methylpropyl)- (9CI);Niaprazinum;Niaprazinum [INN-Latin];Nicotinamide;Nopron;N-[3-[4-(4-Fluorophenyl)-1-piperazinyl]-1-methylpropyl]-3-pyridinecarboxamide;N-[3-[4-(p-Fluorophenyl)-1-piperazinyl]-1-methylpropyl]nicotinamide;3-Pyridinecarboxamide, N-(3-(4-(4-fluorophenyl)-1-piperazinyl)-1-methylpropyl)-, (+)-;DTXSID10865369;Q631457;Niaprazine, (+)-;Niaprazine, (-)-;Nopron (TN);UNII-5QKW305N9F;3-Pyridinecarboxamide, N-(3-(4-(4-fluorophenyl)-1-piperazinyl)-1-methylpropyl)-;1709CERM; Nopron;DB13687;EINECS 248-431-5;1709-CERM;119328-74-4;NIAPRAZINE [INN];NIAPRAZINE [MI];NIAPRAZINE [MART.];N-{4-[4-(4-Fluorophenyl)piperazin-1-yl]butan-2-yl}pyridine-3-carboxamide;119306-37-5;HY-105542;UNII-1346Q758L9;D07333;Niaprazine (INN);AKOS022185020;R2H3YN6E3L;CS-0026220;CHEBI:135505;FT-0687290;NS00006939;Nicotinamide, N-(3-(4-(p-fluorophenyl)-1-piperazinyl)-1-methylpropyl)-;3-Pyridinecarboxamide, N-(3-(4-(4-fluorophenyl)-1-piperazinyl)-1-methylpropyl)-, (-)-;SCHEMBL352977;E75895;AC-36434;27367-90-4;UNII-R2H3YN6E3L;BS-49185;5QKW305N9F;CHEMBL2105141;1346Q758L9;1709CERM;NIAPRAZINE [WHO-DD];J10.716F;MFCD00867991;RSKQGBFMNPDPLR-UHFFFAOYSA-N;DA-66083;Niaprazine; 3-Pyridinecarboxamide, N-[3-[4-(4-fluorophenyl)-1-piperazinyl]-1-methylpropyl]-; Nicotinamide, N-[3-[4-(p-fluorophenyl)-1-piperazinyl]-1-methylpropyl]- (8CI); N-[3-[4-(4-Fluorophenyl)-1-piperazinyl]-1-methylpropyl]-3-pyridinecarboxamide; 1709CERM; Niapraz |